Your Shopping Cart Is Empty
| Report Code: A00470 | Nov 2014 | Pages: 156 | ||
| Tables: 35 | Charts: 37 |
| |
Pandemic disrupted the entire world and affected many industries.
Get detailed COVID-19 impact analysis on the Neuroprosthetics Market
Request Now !Neuroprosthetics Industry Statistics:
Neuroprosthetics Market is expected to garner $14 billion by 2020, registering a CAGR of 15.8% during the forecast period 2014-2020. High prevalence of chronic diseases and growing healthcare awareness has boosted the neuroprosthetics market growth for neuroprosthetic devices/implants. This research report provides pin-point analysis of the global neuroprosthetics market, including market estimates and trends through 2020. The report contains an in-depth analysis of different segments such as neuroprosthetics technologies, types, applications and geography. This report is focused on four major neuroprosthetics technologies namely, deep brain stimulation, spinal cord stimulation, vagus nerve stimulation and sacral nerve stimulation.
The report provides intellect regarding the application of neuroprosthetic devices/implants in the treatment of different diseases such as, parkinson's disease, Alzheimer’s disease, visual impairment and blindness, severe depression, epilepsy, auditory disorders, cardiovascular disorders and kidney disorders. The report confers various value chain entities such as Conventional drug therapy/devices, External/wearable devices, Neurostimulators (brain-machine interfaces), embedded systems. However, the report excludes external stimulation technologies such as transmagnetic stimulation (TMS).
Neuroprosthetic devices/implants are technically advanced products that involves different technologies for its manufacturing/functioning such as local field potential, automated movable electrical probes, MRI, image guided surgical technique etc. These technological developments have occupied neuroprosthetics arena with innumerable replacement strategies, rehabilitation procedures and neuromodulation therapies to improve the quality of life for patients with neuromotor disorders. Advancement in technology has assisted to develop the personalize neurotechnologies and rehabilitation for patient specific neural impairments to accomplish the timely dissemination of neuroprosthetic treatment Cochlear implants and retinal implants are the examples of technologically advanced neuroprosthetic products that have helped deaf and blind population respectively. Argus II retinal prosthesis is EU and USFDA approved commercial available visual prosthesis that improves the vision in patient with retinitis pigmentosa. Thus, with continually advancing technologies, the impact of this factor is expected to augment in near future.
Neuroprosthetics implants/devices are the costlier products that can be afforded by the consumers with high disposable incomes. Moreover, these devices require the training and skills for their use. In developed countries, can afford neuroprosthetics treatments due to presence of high income groups and awareness of these therapies amongst people. However, in emerging neuroprosthetics market people are not much aware about these therapies and requires rigorous training sessions to improve the literacy of people about these therapies to gain the considerable neuroprosthetics market share. Though, emerging market are the lucrative opportunities for neuroprosthetics manufacturers, much focus is needed to improve the knowledge of people about these therapies Increasing government initiative to improve healthcare conditions is assisting patients in emerging economies to achieve the advantage from such therapies. Moreover, in emerging regions, disposable incomes are rising; which has benefited the healthcare industry through expanding healthcare expenses; thus, impact of this factor would grow in future.
Many companies have launched products in different application areas such as, motor neuron disorders, physiological disorders, and other diseased/traumatic neural conditions. Physiological disorders include auditory disorders, ophthalmic disorders, cardiovascular disorders, chronic pain and kidney disorders. Motor neuron disorders includes Parkinson’s disease, epilepsy, dystonia and other movement disorders. Amongst these different application segments, a large number of product approvals, have occurred in the physiological disorders segment, which is shown to be the dominating application for product approval strategy. Numerous products have been approved that uses deep brain stimulation technology for the treatment of different physiological disorders.
Stereotactic implantation refers to minimally invasive procedure that uses 3D co-ordinate system to locate small targets inside the brain and performs certain actions such as biopsy, radiosurgery, ablation, stimulation, injection and implantation on these targeted sites. This technology relay on needle like electrodes that are implanted in the skull through burr holes and reaches into the depths of particular brain areas for recording electroencephalogram. This technology has proved to be vital importance in diagnosis and treatment of neurological disorders such as localization of seizure focus in epileptic patients or assist in controlling tremors by implanting a brain stimulator in the thalamus region. Brain surgery has critical problem of target location as target cannot be located visually. Hence, there is a need of a particular method that can assist in precise target location for neuroprosthetics. Stereotactic implantation involves precise and accurate localization of brain implants. This method is based on devised spatial relationships of brain structures to their landmarks which are visible and expressed by using set of 3 coordinates such as Anterior ‐ Posterior (AP), Medial ‐ Lateral (ML) and Dorsal ‐ Ventral (DL) which is similar to Cartesian coordinate system.
The growth of neuroprosthetics market in Europe is primarily attributed to the increasing burden of chronic neurological conditions. In established European countries the growth of neuroprosthetics market is expected to remain stable, whereas, faster growth is expected in new European Union member states due to considerable funding and modernization of healthcare facilities. Germany, Italy, UK, France and The Netherlands are the biggest market in the European region for neuroprosthetics.
Brain disorders exhibits a considerable social and economic burden in Europe. According to WHO survey, brain disorders are responsible for 35% of Europe’s total disease burden. This burden is increasing due to increasing number of aging population in Europe, and requires a considerable attention to address the treatment issues as all the cases does not respond to medication therapy. Due to this fact scientist have focused on new and advanced treatment options such as neuroprosthetics or brain implants to treat the chronic neurological conditions including Alzheimer’s, Parkinson’s and memory loss due to traumatic brain injury. The prevalence of deafness is high in UK specifically in children (about 350 children per year born deaf, ear foundation, UK) and United Kingdom government has more than 20 well established cochlear implant programs to benefit the deaf population by providing auditory implants. According to BCIG (British Cochlear Implant Group) survey in 2011, about 12,000 people use implants in UK.
Neuroprosthetics Market Research Study Key Benefits:
The global neuroprosthetics market is segmented base on technology, type, application, and geography.
Neuroprosthetics Market Report Highlights
| Aspects | Details |
|---|---|
| By Technology |
|
| By Type |
|
| By Application |
|
| By Geography |
|
| By Key Players of Neuroprosthetics Market: |
|
TABLE OF CONTENTS
CHAPTER 1 INTRODUCTION
1.1 Report Description
1.2 Key Benefits
1.3 Key Market Segments
1.4 Key Audiences
1.5 Research Methodology
1.5.1 Primary Research
1.5.2 Secondary Research
1.5.3 Analyst tools and models
CHAPTER 2 EXECUTIVE SUMMARY
2.1 Market beyond what to expect by 2025 ($Million)
2.1.1 Moderate growth scenario
2.1.2 Rapid growth scenario
2.1.3 Diminishing growth scenario
CHAPTER 3 MARKET OVERVIEW
3.1 Market Definition and Scope
3.2 Addressable Market Scenario
3.3 Ethical Considerations
3.4 Key Findings
3.4.1 Top Factors Impacting on global neuroprosthetics market
3.4.2 Top Investment Pockets of global neuroprosthetics market
3.4.3 Top winning strategies of global neuroprosthetics market
3.5 Advances in neuroprosthetic implantation
3.5.1 Stereotactic implantation
3.5.1.1 Historical Perspective
3.5.1.2Current Trends
3.5.1.2.1 INCREASING USE OF MRI, CT SCANS AND OTHER IMAGE GUIDING SYSTEMS FOR STEREOTACTIC IMPLANTATION
3.5.1.2.2 ROBOTS FOR IMPROVED STEREOTAXIC PRECISION
3.5.1.3 Competitive scenario
3.5.2 Electrophysiological mapping
3.5.2.1 Historical Perspective
3.5.2.2 Current Trends
3.5.2.2.1 EVOKED POTENTIAL MONITORING
3.5.2.2.2 SINGLE-UNIT RECORDINGS
3.5.2.3 Competitive scenario
3.6 Government Regulations
3.6.1 Medical Devices regulations in United States (U.S.)
3.6.2 Medical Devices regulations in Europe and UK
3.6.3 Medical Devices regulations in Asia-Pacific
3.6.4 Regulatory approval timeframe in different regions
3.7 Patent Analysis
3.7.1 Patent analysis by geographies (2010-2014)
3.7.2 Patent analysis based on medical condition (2011-2014)
3.8 Clinical Trials for Neuroprosthetics
3.9 Value chain analysis
3.9.1 Brain Machine interfaces and neurostimulators
3.9.2 Embedded neuroprosthetic devices/implants
3.10 Market Share Analysis
3.11 Market Dynamics
3.11.1 Drivers
3.11.1.1 Rapid progression of technology assist in improving neuroprosthetics
3.11.1.2 New device approvals- leading towards early commercialization to achieve competitive edge
3.11.1.3 Rising burden of neurological disorders that responds to neurostimulation
3.11.1.4 Availability of Funds and research grants
3.11.2 Restraints
3.11.2.1 Reimbursement Issues have negative impact on neuroprosthetics adoption rate
3.11.2.2 Adverse reactions- increases risk of mortality and decreases usage rate
3.11.2.3 High cost of product and therapy
3.11.3 Opportunities
3.11.3.1 Early commercialization of pipeline products assists to gain competitive advantage
CHAPTER 4 GLOBAL NEUROPROSTHETICS MARKET BY TECHNOLOGY, 2013-2020, $MILLION
4.1 Deep Brain Simulation (DBS)
4.1.1 Historical Perspective
4.1.2 Current Trends
4.1.2.1 Advancement in component system
4.1.2.2 Other technological advances
4.1.3 Competitive Scenario
4.2 Vagus Nerve Stimulation (VNS)
4.2.1 Historical Perspective
4.2.2 Current trends
4.2.2.1 Direct and transcutaneous vagus nerve stimulators are gaining popularity
4.2.3 Competitive Scenario
4.3 Spinal Cord Stimulation (SCS)
4.3.1 Historical Perspective
4.3.2 Current trends
4.3.2.1 Rechargeable neurostimulation system gaining significant attention
4.3.2.1.1 RESTORE RECHARGEABLE NEUROSTIMULATION SYSTEM
4.3.2.1.2 EON NEUROSTIMULATION SYSTEM
4.3.2.1.3 PRECISION SPINAL CORD STIMULATION SYSTEM
4.3.3 Competitive Scenario
4.4 Sacral Nerve Stimulation (SNS)
4.4.1 Historical Perspective
4.4.2 Current trends
CHAPTER 5 GLOBAL NEUROPROSTHETICS MARKET BY TYPE, 2013-2020, $MILLION
5.1 Motor Prosthetics
5.1.1 Key Market Trends
5.1.2 Key growth factors and opportunities
5.1.3 Market Size and forecast
5.2 Auditory Prosthetics / Cochlear Implants
5.2.1 Key Market Trends
5.2.2 Key growth factors and opportunities
5.2.3 Market Size and forecast
5.3 Visual Prosthetics / Retinal Implants
5.3.1 Key Market Trends
5.3.2 Key growth factors and opportunities
5.3.3 Market Size and forecast
5.4 Cognitive Prosthetics
5.4.1 Key Market Trends
5.4.2 Key growth factors and opportunities
5.4.3 Market Size and forecast
CHAPTER 6 GLOBAL NEUROPROSTHETICS MARKET BY APPLICATION, 2013-2020, $MILLION
6.1 Motor Neuron disorders
6.1.1 Parkinsons disease
6.1.2 Epilepsy
6.2 Physiological disorders
6.2.1 Auditory disorders
6.2.2 Ophthalmic disorders
6.2.3 Cardiac disorders
6.2.4 Kidney disorders
6.3 Cognitive disorders
6.3.1 Alzheimer's disease
6.3.2 Severe depression
CHAPTER 7 GLOBAL NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2013-2020, $MILLION
7.1 North America
7.1.1 Key market trends
7.1.2 Competitive scenario
7.1.3 Key growth factors and opportunities
7.1.4 Market size and forecast
7.2 Europe
7.2.1 Key market trends
7.2.2 Competitive scenario
7.2.3 Key growth factors and opportunities
7.2.4 Market size and forecast
7.3 Asia-Pacific
7.3.1 Key market trends
7.3.2 Competitive scenario
7.3.3 Key growth factors and opportunities
7.3.4 Market size and forecast
7.4 LAMEA
7.4.1 Key market trends
7.4.2 Competitive scenario
7.4.3 Key growth factors and opportunities
7.4.4 Market size and forecast
CHAPTER 8 COMPANY PROFILES
8.1 Boston Scientific Corporation
8.1.1 Overview
8.1.2 Company snapshot
8.1.3 Operating Business Segments
8.1.4 Financial performance
8.1.5 Strategic moves and developments
8.1.6 SWOT analysis
8.2 Cochlear Limited
8.2.1 Overview
8.2.2 Company snapshots
8.2.3 Operating Business Segments
8.2.4 Financial performance
8.2.5 Strategic moves and developments
8.2.6 SWOT analysis
8.3 Cyberonics Inc.
8.3.1 Overview
8.3.2 Company snapshot
8.3.3 Operating Business Segments
8.3.4 Financial performance
8.3.5 Strategic moves and developments
8.3.6 SWOT analysis
8.4 Medtronic Inc.
8.4.1 Company overview
8.4.2 Company snapshots
8.4.3 Operating Business Segments
8.4.4 Financial performance
8.4.5 Strategic moves and developments
8.4.6 SWOT Analysis
8.5 NDI Medical LLC
8.5.1 Overview
8.5.2 Company snapshot
8.5.3 Operating Business Segments
8.5.4 Strategic moves and developments
8.5.5 SWOT analysis
8.6 Nervo Corp.
8.6.1 Overview
8.6.2 Company snapshot
8.6.3 Operating Business Segments
8.6.4 Strategic moves and developments
8.6.5 SWOT analysis
8.7 NeuroPace Inc.
8.7.1 Overview
8.7.2 Company snapshot
8.7.3 Operating Business Segments
8.7.4 Strategic moves and developments
8.7.5 SWOT analysis
8.8 Retina Implant AG
8.8.1 Overview
8.8.2 Company snapshot
8.8.3 Operating Business Segments
8.8.4 Strategic moves and developments
8.8.5 SWOT analysis
8.9 ST. Jude Medical
8.9.1 Overview
8.9.2 Company snapshot
8.9.3 Operating Business Segments
8.9.4 Financial performance
8.9.5 Strategic moves and developments
8.9.6 SWOT analysis
8.10 Sonova Group (Advanced Bionics AG)
8.10.1 Company overview
8.10.2 Company snapshots
8.10.3 Operating Business Segments
8.10.4 Financial performance
8.10.5 Strategic moves and developments
8.10.6 SWOT analysis
List of Figures
FIG. 1 TOP FACTORS IMPACTING NEUROPROSTHETICS MARKET (2013-2020)
FIG. 2 TOP INVESTMENT POCKETS OF GLOBAL NEUROPROSTHETICS MARKET(2013)
FIG. 3 TOP WINING STRATEGIES FOR GLOBAL NEUROPROSTHETICS MARKET (2011-2014)
FIG. 4 STRATEGIC SHARE OF NEUROPROSTHETICS APPLICATION
FIG. 5 TOP WINING STRATEGIES BY NEUROPROSTHETICS APPLICATION
FIG. 6 FDA APPROVED INDICATIONS FOR NEUROPROSTHETICS
FIG. 7 AVERAGE APPROVAL TIME FOR DIFFERENT CLASSES OF MEDICAL DEVICE IN LEADING MARKETS IN 2013
FIG. 8 PATENT ANALYSIS BY GEOGRAPHIES (2011-2014)
FIG. 9 PATENT ANALYSIS BASED ON MEDICAL CONDITION(2011-2014)
FIG. 10 NEUROPROSTHETICS- VALUE CHAIN
FIG. 11 GLOBAL NEUROPROSTHETICS MARKET SHARE ANALYSIS (2013)
FIG. 12 GLOBAL MOTOR PROSTHETICS MARKET, 2013-2020 ($MILLION)
FIG. 13 GLOBAL AUDITORY PROSTHETICS MARKET, 2013-2020 ($MILLION)
FIG. 14 GLOBAL VISUAL PROSTHETICS MARKET, 2013-2020 ($MILLION)
FIG. 15 GLOBAL COGNITIVE PROSTHETICS MARKET, 2013-2020 ($MILLION)
FIG. 16 PREVALENCE OF ALZHEIMERS DISEASE IN UNITED STATES, BY AGE (2014)
FIG. 17 REVENUE OF BOSTON SCIENTIFIC CORPORATION. BY GEOGRAPHY(2013)
FIG. 18 REVENUE BOSTON SCIENTIFIC CORPORATION. BY PRODUCT GROUPS(2013)
FIG. 19 SWOT ANALYSIS OF BOSTON SCIENTIFIC CORPORATION.
FIG. 20 REVENUE OF COCHLEAR CORPORATION LTD. BY GEOGRAPHY(2014)
FIG. 21 REVENUE OF COCHLEAR CORPORATION LTD. BY PRODUCT GROUPS(2014)
FIG. 22 SWOT ANALYSIS OF MEDTRONIC INC.
FIG. 23 REVENUE OF CYBERONICS INC. BY GEOGRAPHY(2014)
FIG. 24 SWOT ANALYSIS OF CYBERONICS INC.
FIG. 25 REVENUE OF MEDTRONIC INC. BY GEOGRAPHY(2013)
FIG. 26 REVENUE MEDTRONIC INC. BY BUSINESS GROUP(2013)
FIG. 27 SWOT ANALYSIS OF MEDTRONIC INC.
FIG. 28 SWOT ANALYSIS OF NDI MEDICAL LLC.
FIG. 29 SWOT ANALYSIS OF NERVO CORP.
FIG. 30 SWOT ANALYSIS OF NEUROPACE INC.
FIG. 31 SWOT ANALYSIS OF NEUROPACE INC.
FIG. 32 NET SALES OF ST. JUDE MEDICAL. BY GEOGRAPHY(2013)
FIG. 33 NET SALES OF ST. JUDE MEDICAL. BY BUSINESS GROUP(2013)
FIG. 34 SWOT ANALYSIS OF ST. JUDE MEDICAL.
FIG. 35 REVENUE OF SONOVA GROUP. BY GEOGRAPHY(2013/14)
FIG. 36 REVENUE SONOVA GROUP. BY PRODUCT GROUPS(2013/14)
FIG. 37 SWOT ANALYSIS OF SONOVA HOLDING AG.
List of Tables
TABLE 1 MODERATE GROWTH SCENARIO OF NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2020-2025, ($MILLION)
TABLE 2 RAPID GROWTH SCENARIO OF NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2020-2025, ($MILLION)
TABLE 3 DIMINISHING GROWTH SCENARIO OF NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2020-2025, ($MILLION)
TABLE 4 MEDICAL DEVICE CATEGORIES LISTED BY EC
TABLE 1 PATENT ANALYSIS BY GEOGRAPHIES (2011-2014)
TABLE 2 CLINICAL TRIALS FOR NEUROPROSTHETICS
TABLE 3 CURRENT RESEARCH IN EMERGING TECHNOLOGIES AND THEIR APPLICATIONS IN NEUROPROSTHETICS
TABLE 4 LIST OF USFDA APPROVED, COMMERCIALLY AVAILABLE NEUROPROSTHETICS
TABLE 5 GLOBAL PREVALENCE OF NEUROLOGICAL DISORDERS
TABLE 6 AVERAGE COST OF NEUROPROSTHETIC THERAPY/ PRODUCTS
TABLE 7 GLOBAL NEUROPROSTHETICS MARKET BY TECHNOLOGY, 2013-2020 ($MILLION)
TABLE 8 FDA APPROVED APPLICATIONS FOR DEEP BRAIN STIMULATION
TABLE 9 VAGUS NERVE STIMULATION DEVICE: FACT SHEET
TABLE 10 GLOBAL NEUROPROSTHETICS MARKET BY TYPES, 2013-2020 ($MILLION)
TABLE 11 COMPANIES AND THEIR FDA APPROVED COCHLEAR IMPLANTS
TABLE 12 GLOBAL NEUROPROSTHETICS MARKET BY APPLICATION, 2013-2020 ($MILLION)
TABLE 13 PARKINSONS DISEASE NEUROPROSTHETICS MARKET, 2013-2020 ($MILLION)
TABLE 14 EPILEPSY NEUROPROSTHETICS MARKET, 2013-2020 ($MILLION)
TABLE 15 GLOBAL ESTIMATE AND PREVALENCE OF DISABLING HEARING LOSS, IN ADULTS 15 YEARS OR OLDER AND CHILDREN 0-14 YEARS (MILLIONS AND PERCENTAGE OF POPULATION)
TABLE 16 AUDITORY DISORDERS NEUROPROSTHETICS MARKET, 2013-2020 ($MILLION)
TABLE 17 OPHTHALMIC DISORDERS NEUROPROSTHETICS MARKET, 2013-2020 ($MILLION)
TABLE 18 NEUROCARDIAC DISORDERS NEUROPROSTHETICS MARKET, 2013-2020 ($MILLION)
TABLE 19 KIDNEY DISORDERS NEUROPROSTHETICS MARKET, 2013-2020 ($MILLION)
TABLE 20 ALZHEIMEERS DISEASE NEUROPROSTHETICS MARKET, 2013-2020 ($MILLION)
TABLE 21 SEVERE DEPRESSION NEUROPROSTHETICS MARKET, 2013-2020 ($MILLION)
TABLE 22 GLOBAL NEUROPROSTHETICS MARKET BY GEOGRAPHY, 2013-2020 ($MILLION)
TABLE 23 NORTH AMERICA NEUROPROSTHETICS MARKET BY VALUE, 2013-2020 ($MILLION)
TABLE 24 EUROPE NEUROPROSTHETICS MARKET BY VALUE, 2013-2020 ($MILLION)
TABLE 25 ASIA-PACIFIC NEUROPROSTHETICS MARKET BY VALUE, 2013-2020 ($MILLION)
TABLE 26 LAMEA NEUROPROSTHETICS MARKET BY VALUE, 2013-2020 ($MILLION)
TABLE 27 BOSTON SCIENTIFIC CORPORATION SNAPSHOT
TABLE 28 BOSTON SCIENTIFIC CORPORATION OPERATING SEGMENTS
TABLE 29 COCHLEAR CORPORATION SNAPSHOT
TABLE 30 COCHLEAR CORPORATION OPERATING SEGMENTS
TABLE 31 CYBERONICS INC SNAPSHOT
TABLE 32 MEDTRONIC SNAPSHOT
TABLE 33 MEDTRONIC OPERATING SEGMENTS
TABLE 34 NDI MEDICAL SNAPSHOT
TABLE 35 NDI MEDICAL LLC OPERATING SEGMENTS
TABLE 36 NERVO CORP. SNAPSHOT
TABLE 37 NEUROPACE INC. SNAPSHOT
TABLE 38 RETINA IMPLANT AG SNAPSHOT
TABLE 39 ST. JUDE MEDICAL SNAPSHOT
TABLE 40 ST. JUDE MEDICAL OPERATING SEGMENTS
TABLE 41 SONOVA GROUP SNAPSHOT
TABLE 42 SONOVA GROUP OPERATING SEGMENTS
Start reading instantly.
This Report and over 66,905+ more Reports, Available with Avenue Library. T&C*.
Enterprise
License/PDF
Library
Membership
*Taxes/Fees, if applicable will be added during checkout. All prices in USD
To ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Get insights on topics that are crucial for your business. Stay abreast of your interest areas.
Get Industry Data AlertsTo ensure high-level data integrity, accurate analysis, and impeccable forecasts
For complete satisfaction
On-demand customization of scope of the report to exactly meet your needs
Targeted market view to provide pertinent information and save time of readers
Contact Details
Need to talk to an expert? Book your free consultation and let our research experts help you with your needs/problems.
Global Report 
Regional Report
Country Report
Related Report